Multisorb used the recent Interphex trade show to introduce its new
range of consulting services to accompany its well-known range of
sorbent products and save customers both time and money in drug
Dutch biotechnology firm Crucell has announced it will sell vaccine
manufacturer Rhein Biotech to US company Dynavax for around $12m
(€10m) as it chooses to focus on specialised vaccines such as those
for Ebola and malaria.
The Optima Group's presence at this year's Interphex show in New
York was significant as it gave In-PharmaTechnologist.com the first
look at the Group's recently implemented shift in focus, resulting
in a product range...
LGC Promochem has launched its 2006 edition of its free
pharmaceutical reference substances and impurities catalogue,
providing researchers and analysts in the pharmaceutical R&D
and manufacturing generic industry with a central...
Laureate Pharma, a full service biopharmaceutical development and
protein production company, has been given a new contract by
Bradmer Pharmaceuticals to develop and manufacture its novel brain
cancer treatment for Phase III clinical...
Responding to surging demand for its flu drug Tamiflu, Roche has
announced it is expanding its external contractors to fifteen in
nine different countries, as its needs for intermediates and
finished product increase.
Millipore are to showcase a range of filtration, chromatography,
process monitoring and water purification solutions that are a part
of Millipore's response to an increase in lab investments from
pharma companies, and the emergence...
Canadian drug outsourcing company Patheon has reported its first
quarterly loss since its inception in 1974, swinging from a net
profit of $6m (€4.9m) in Q1 of 2005 to a net loss of $11.5m in Q1
of 2006, as problems with production...
Looking for an advantage in the high-value generics market and a
boost to its contract development services for research-driven
pharmaceutical companies, Swiss chemicals and pharmaceuticals group
Schweizerhall has bought German drug...
In its first venture outside the subcontinent, though certainly not
the last of its kind for India pharma companies, contract
pharmaceuticals manufacturer Kemwell has bought for an undisclosed
sum Pfizer's production plant in...
Anticipating a US Food and Drug Administration (FDA) approval this
year, Dendreon has awarded Diosynth Biotechnology with a long-term
contract to supply the recombinant protein antigen component of its
novel vaccine for prostate cancer...
Swiss QC specialist SGS has opened a laboratory in Singapore for
the contract testing of pharmaceuticals, biopharmaceuticals and
medical devices, eying a budding market which seems hungry for
Swiss custom manufacturing firm Lonza has entered into a joint
venture with investment management company Bio*One Capital to built
a $250m (€210m) large-scale mammalian cell culture plant in
Singapore, underlying Lonza's confidence...